101 related articles for article (PubMed ID: 22850536)
21. Immunization of protein HPV16 E7 in fusion with mouse HSP70 inhibits the growth of TC-1 cells in tumor bearing mice.
Li YL; Liu J; Liu JN; Zhang J
Vaccine; 2011 Aug; 29(35):5959-62. PubMed ID: 21722685
[TBL] [Abstract][Full Text] [Related]
22. DNA vaccine encoding endosome-targeted human papillomavirus type 16 E7 protein generates CD4+ T cell-dependent protection.
Brulet JM; Maudoux F; Thomas S; Thielemans K; Burny A; Leo O; Bex F; Hallez S
Eur J Immunol; 2007 Feb; 37(2):376-84. PubMed ID: 17274002
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus E7 oncoprotein increases production of the anti-inflammatory interleukin-18 binding protein in keratinocytes.
Richards KH; Doble R; Wasson CW; Haider M; Blair GE; Wittmann M; Macdonald A
J Virol; 2014 Apr; 88(8):4173-9. PubMed ID: 24478434
[TBL] [Abstract][Full Text] [Related]
24. Expression and purification of His-tagged HPV16 E7 protein active in pRb binding.
Mirecka EA; Rudolph R; Hey T
Protein Expr Purif; 2006 Aug; 48(2):281-91. PubMed ID: 16814565
[TBL] [Abstract][Full Text] [Related]
25. In Planta production of immunogenic poliovirus peptide using tobacco mosaic virus-based vector system.
Fujiyama K; Saejung W; Yanagihara I; Nakado J; Misaki R; Honda T; Watanabe Y; Seki T
J Biosci Bioeng; 2006 May; 101(5):398-402. PubMed ID: 16781468
[TBL] [Abstract][Full Text] [Related]
26. Expression optimization of a cell membrane-penetrating human papillomavirus type 16 therapeutic vaccine candidate in Nicotiana benthamiana.
Yanez RJR; Lamprecht R; Granadillo M; Weber B; Torrens I; Rybicki EP; Hitzeroth II
PLoS One; 2017; 12(8):e0183177. PubMed ID: 28800364
[TBL] [Abstract][Full Text] [Related]
27. Trastuzumab-binding peptide display by Tobacco mosaic virus.
Frolova OY; Petrunia IV; Komarova TV; Kosorukov VS; Sheval EV; Gleba YY; Dorokhov YL
Virology; 2010 Nov; 407(1):7-13. PubMed ID: 20801474
[TBL] [Abstract][Full Text] [Related]
28. [Expression, purification and immunogenicity of human papillomavirus type 11 virus-like particles from Escherichia coli].
Yan C; Li S; Wang J; Wei M; Huang B; Zhuang Y; Li Z; Pan H; Zhang J; Xia N
Wei Sheng Wu Xue Bao; 2009 Nov; 49(11):1527-33. PubMed ID: 20112683
[TBL] [Abstract][Full Text] [Related]
29. Low-dose adenovirus vaccine encoding chimeric hepatitis B virus surface antigen-human papillomavirus type 16 E7 proteins induces enhanced E7-specific antibody and cytotoxic T-cell responses.
Báez-Astúa A; Herráez-Hernández E; Garbi N; Pasolli HA; Juárez V; Zur Hausen H; Cid-Arregui A
J Virol; 2005 Oct; 79(20):12807-17. PubMed ID: 16188983
[TBL] [Abstract][Full Text] [Related]
30. His6-tagged UL35 protein of duck plague virus: expression, purification, and production of polyclonal antibody.
Cai MS; Cheng AC; Wang MS; Zhao LC; Zhu DK; Luo QH; Liu F; Chen XY
Intervirology; 2009; 52(3):141-51. PubMed ID: 19478528
[TBL] [Abstract][Full Text] [Related]
31. Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.
Gambhira R; Gravitt PE; Bossis I; Stern PL; Viscidi RP; Roden RB
Cancer Res; 2006 Dec; 66(23):11120-4. PubMed ID: 17145854
[TBL] [Abstract][Full Text] [Related]
32. DNA vaccine against human papillomavirus type 16: modifications of the E6 oncogene.
Poláková I; Pokorná D; Dusková M; Smahel M
Vaccine; 2010 Feb; 28(6):1506-13. PubMed ID: 20003917
[TBL] [Abstract][Full Text] [Related]
33. Purified herpes simplex type 1 glycoprotein D (gD) genetically fused with the type 16 human papillomavirus E7 oncoprotein enhances antigen-specific CD8+ T cell responses and confers protective antitumor immunity.
Porchia BF; Diniz MO; Cariri FA; Santana VC; Amorim JH; Balan A; Braga CJ; Ferreira LC
Mol Pharm; 2011 Dec; 8(6):2320-30. PubMed ID: 21985578
[TBL] [Abstract][Full Text] [Related]
34. Cysteine-rich positions outside the structural zinc motif of human papillomavirus E7 provide conformational modulation and suggest functional redox roles.
Chemes LB; Camporeale G; Sánchez IE; de Prat-Gay G; Alonso LG
Biochemistry; 2014 Mar; 53(10):1680-96. PubMed ID: 24559112
[TBL] [Abstract][Full Text] [Related]
35. Strong immune responses induced by a DNA vaccine containing HPV16 truncated E7 C-terminal linked to HSP70 gene.
Meshkat Z; Soleimanjahi H; Mirshahabi H; Meshkat M; Kheirandish M; Hassan ZM
Iran J Immunol; 2011 Jun; 8(2):65-75. PubMed ID: 21705833
[TBL] [Abstract][Full Text] [Related]
36. Potato virus X coat protein fusion to human papillomavirus 16 E7 oncoprotein enhance antigen stability and accumulation in tobacco chloroplast.
Morgenfeld M; Segretin ME; Wirth S; Lentz E; Zelada A; Mentaberry A; Gissmann L; Bravo-Almonacid F
Mol Biotechnol; 2009 Nov; 43(3):243-9. PubMed ID: 19579017
[TBL] [Abstract][Full Text] [Related]
37. Complementation studies of the DnaK-DnaJ-GrpE chaperone machineries from Vibrio harveyi and Escherichia coli, both in vivo and in vitro.
Zmijewski MA; Kwiatkowska JM; Lipińska B
Arch Microbiol; 2004 Dec; 182(6):436-49. PubMed ID: 15448982
[TBL] [Abstract][Full Text] [Related]
38. Affinity purification of streptavidin using tobacco mosaic virus particles as purification tags.
Negrouk V; Eisner G; Midha S; Lee HI; Bascomb N; Gleba Y
Anal Biochem; 2004 Oct; 333(2):230-5. PubMed ID: 15450797
[TBL] [Abstract][Full Text] [Related]
39. Expression of soluble, biologically active recombinant human endostatin in Escherichia coli.
Xu HM; Zhang GY; Ji XD; Cao L; Shu L; Hua ZC
Protein Expr Purif; 2005 Jun; 41(2):252-8. PubMed ID: 15866710
[TBL] [Abstract][Full Text] [Related]
40. Potatovirus X and Tobacco mosaic virus-based vectors compatible with the Gateway cloning system.
Lacorte C; Ribeiro SG; Lohuis D; Goldbach R; Prins M
J Virol Methods; 2010 Mar; 164(1-2):7-13. PubMed ID: 19903495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]